173 related articles for article (PubMed ID: 35490318)
1. Transcriptomic Signatures in Colorectal Cancer Progression.
Ershov P; Poyarkov S; Konstantinova Y; Veselovsky E; Makarova A
Curr Mol Med; 2023; 23(3):239-249. PubMed ID: 35490318
[TBL] [Abstract][Full Text] [Related]
2. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
6. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
Pirim D
Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
[TBL] [Abstract][Full Text] [Related]
7. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
8. Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.
Hameed Y; Usman M; Liang S; Ejaz S
PLoS One; 2021; 16(9):e0256020. PubMed ID: 34473751
[TBL] [Abstract][Full Text] [Related]
9. Identification of hub genes and pathways in lung metastatic colorectal cancer.
Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
[TBL] [Abstract][Full Text] [Related]
11. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
12. Identification and Verification of Core Genes in Colorectal Cancer.
Xu H; Ma Y; Zhang J; Gu J; Jing X; Lu S; Fu S; Huo J
Biomed Res Int; 2020; 2020():8082697. PubMed ID: 32462020
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential core genes in colorectal carcinoma and key genes in colorectal cancer liver metastasis using bioinformatics analysis.
Niu L; Gao C; Li Y
Sci Rep; 2021 Dec; 11(1):23938. PubMed ID: 34907282
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer.
Wang Y; Zheng K; Chen X; Chen R; Zou Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345281
[TBL] [Abstract][Full Text] [Related]
15. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
17. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B; Li C; Zhao J
Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
[TBL] [Abstract][Full Text] [Related]
19. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
20. Identification and clinical validation of key genes as the potential biomarkers in colorectal adenoma.
Wang B; Zhang J; Wang X; Zhao L; Wang Y; Fan Z; Liu L; Gao W
BMC Cancer; 2023 Jan; 23(1):39. PubMed ID: 36631756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
